title: Rare-disease drugs to receive consideration on par with serious-disease drugs.
authors.forename: Cheryl A
authors.initials: CA
authors.lastname: Thompson
mesh_terms: D017277:Drug Approval / Q000331:legislation & jurisprudence*; D006801:Humans; D009965:Orphan Drug Production / Q000331:legislation & jurisprudence*; D035583:Rare Diseases / Q000188:drug therapy* / Q000503:physiopathology; D014481:United States; D014486:United States Food and Drug Administration